Josh Rowe

Josh Rowe is an experienced executive in drug discovery and development, currently serving as Executive Director at AbbVie since May 2020. Prior to this role, Josh held various positions at Allergan from October 2000 to May 2020, including Executive Director, Drug Metabolism, and Director, Drug Metabolism PK, focusing on bioanalytical mass spectrometry, drug metabolism, and ADMET screening. Earlier career experience includes roles at Eli Lilly and Dow AgroSciences, starting as an Associate Analytical Chemist and progressing through various scientific ranks. Josh holds a BS in Chemistry from Purdue University, earned between 1992 and 1995, and is ACS Certified.